Salesforce’s Stock Is Historically Cheap as AI Risk Takes a Toll

Salesforce shares are trading at multi-year lows even as management projects double-digit revenue growth in the coming years and the company prepares to report quarterly results after the bell. Investors and Wall Street remain skeptical—focusing on the risk that AI could erode Salesforce's growth trajectory—which has kept a cautious narrative around the stock and pressured valuation despite the upbeat guidance.

Analysis

Market structure: AI-native infrastructure vendors (NVDA, MSFT, GOOGL) are the primary beneficiaries as they capture incremental spend for model training and cloud compute; legacy app-layer vendors like CRM face revenue mix and pricing-pressure risk as AI features commoditize. Expect 200–500bp pressure on organic license growth vectors over 12–24 months if customers buy point AI tools instead of premium CRM modules, and a near-term supply/demand imbalance in the stock as institutional flows pull back into perceived AI winners.

Risk assessment: Tail risks include rapid enterprise migration to hyperscaler-integrated CRM ( >10% market share shift in 12–24 months), privacy/regulatory constraints limiting data-driven AI features, or a material guidance miss triggering >20% downside in days. Immediate (days) risk centers on volatile post-earnings moves; short-term (weeks–months) on analyst revisions and desktop wins/losses; long-term (quarters–years) on structural TAM change and margin mix. Hidden dependencies: Salesforce’s monetization is tied to ecosystem stickiness (AppExchange, large-contract renewals) — losses there cascade into FCF, buyback capacity, and multiples.

Trade implications: If CRM gaps down >5% post-earnings, that is a tactical buying window for a hedged long (see decisions). If management cuts guidance by >200bps, implement short via puts (3–6 month) sized to 1–2% portfolio risk. Favor rotating 3–5% from application SaaS into AI infrastructure (NVDA, MSFT, GOOGL) over 90 days; use 3–6 month option structures (buy OTM puts for protection, buy/roll call spreads for upside) to manage volatility.

Contrarian angles: Consensus underestimates that AI features can increase switching costs by embedding proprietary enterprise data into Salesforce workflows — a positive for stickiness that could re-rate CRM by 15–30% once product proofs arrive (6–12 months). The current sell-off may be overdone by 10–25% on sentiment alone, creating an asymmetric risk/reward for disciplined, hedged entry. Unintended consequence: a lower market cap increases probability of aggressive buybacks or strategic M&A interest, which would be a positive catalyst for shareholders.

Key Decisions for Investors

• Establish a 2–3% long equity position in CRM only if post-earnings price action gaps down >5% intraday; pair the purchase with 3-month puts 8% OTM (protect ~80% of downside) and set a profit target of +15% within 6–12 months and a hard stop if trade loses 12% after hedging costs.
• If Salesforce issues guidance cut or organic revenue miss >200bps, initiate a tactical short sized to 1–2% portfolio risk by buying 3–6 month CRM puts 8–12% OTM (target 20–30% downside within 6 months); hedge directional exposure by purchasing NVDA (1–1.5% weight) to capture AI infrastructure upside.
• Rotate 3–5% of portfolio from legacy application SaaS names (reduce CRM/HUBS exposure proportionally) into AI infrastructure: NVDA (2%), MSFT (1.5%), GOOGL (1.5%). Rebalance after 90 days or upon 10% move in either direction; trim if NVDA/MSFT sector gains exceed 25%.
• If preferring options: sell 6–9 month covered calls on existing CRM holdings at ~12–15% OTM to monetize premium while retaining upside; alternatively, buy a 6-month CRM call spread (ATM to +15% strike) if you want capped-cost upside exposure ahead of anticipated product proofs within 6–12 months.